1. Home
  2. TZOO vs INMB Comparison

TZOO vs INMB Comparison

Compare TZOO & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Travelzoo

TZOO

Travelzoo

HOLD

Current Price

$5.66

Market Cap

59.4M

ML Signal

HOLD

Logo INmune Bio Inc.

INMB

INmune Bio Inc.

HOLD

Current Price

$2.03

Market Cap

64.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TZOO
INMB
Founded
1998
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
59.4M
64.7M
IPO Year
2003
2018

Fundamental Metrics

Financial Performance
Metric
TZOO
INMB
Price
$5.66
$2.03
Analyst Decision
Strong Buy
Buy
Analyst Count
2
5
Target Price
★ $17.50
$5.40
AVG Volume (30 Days)
45.4K
★ 315.2K
Earning Date
04-23-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 11.85
EPS
★ 0.03
N/A
Revenue
N/A
★ $50,000.00
Revenue This Year
$11.98
N/A
Revenue Next Year
$9.52
N/A
P/E Ratio
$183.67
★ N/A
Revenue Growth
N/A
★ 257.14
52 Week Low
$4.72
$1.09
52 Week High
$12.39
$2.60

Technical Indicators

Market Signals
Indicator
TZOO
INMB
Relative Strength Index (RSI) 30.52 43.69
Support Level $5.48 $1.97
Resistance Level $6.07 $2.17
Average True Range (ATR) 0.24 0.16
MACD 0.06 -0.05
Stochastic Oscillator 25.00 15.15

Price Performance

Historical Comparison
TZOO
INMB

About TZOO Travelzoo

Travelzoo acts as a publisher of travel and entertainment offers. It operates in four segments. Travelzoo North America segment, which is the key revenue driver, consists of operations in Canada and the U.S.; Travelzoo Europe segment consists of operations in France, Germany, Spain, and the U.K.; Jack's Flight Club segment consists of subscription revenue from premium members to access and receive flight deals from Jack's Flight Club via email or via Android or Apple mobile applications; and New Initiatives consists of Travelzoo's licensing activities in Asia Pacific territories. It derives its revenue through advertising fees including listing fees paid by travel, entertainment, and local businesses to advertise their offers on the company's media properties.

About INMB INmune Bio Inc.

INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.

Share on Social Networks: